Accordingly, the induction of JNK and inhibition of ERK activity leads to apoptosis and differentiation of intestinal cells, which could be considered as a new strategy to prevent CRC development and a potential target for cancer therapy (7, 43, 44). Here, MAPK8 is linked to colorectal carcinoma.